Biotechnology Valuation

Shares of Raptor Pharmaceutical Corp. (NASDAQ: RPTP) were trading higher by more than 20 percent Monday after the company agreed to be acquired by Horizon Pharma PLC (NASDAQ: HZNP) for $800 million, or $9 per share. Speaking as a guest on Monday's Premarket Prep, Martin Shkreli shared his...